Time filter

Source Type


Agency: Department of Health and Human Services | Branch: National Institutes of Health | Program: SBIR | Phase: Phase I | Award Amount: 209.30K | Year: 2015

DESCRIPTION provided by applicant The goal of this Phase I application is to develop a nanoparticle and surface enhanced Raman spectroscopy SERS based molecular detection system to directly detect norovirus gastroenteritis without the use of target amplification techniques such as polymerase chain reaction or isothermal amplification Noroviruses are the most common cause of epidemic gastroenteritis According to the CDC noroviruses are the most common cause of foodborne disease outbreaks in the United States Norovirus outbreaks can affect people in a variety of settings For example norovirus outbreaks in military forces are regularly reported The virus affects around million people and causes over deaths each year these deaths are usually in less developed countries and in the very young elderly and immuno suppressed Norovirus infections are highly contagious as the infectious dose is less than virus particles and the virus is shed to high titers of particles per gram in the feces We propose to use multifunctional gold coated magnetic nanoparticle AuMNPs and SERS based molecular detection system to capture and detect norovirus RNA in stool samples After sample lysing the capture purification and detection of norovirus RNA will be achieved using AuMNPs that have been functionalized with positively charged peptide nucleic acid capture probes ve PNA and intrinsically strong Raman labels These multifunctional nano sized AuMNPs nm provide for a more rapid and efficient capture of RNA than those offered by micron size particles or dimensional sensing surfaces The use of Raman labels on the AuMNPs as a single tag takes advantage of the well established surface enhancing characteristics of Raman reporter molecules coated on gold nanoparticles Working with nanotechnology expert Chuan Jian Zhong SUNY Binghamton we will develop and optimize the AuMNPs to capture RNA and to form a Raman tag for the direct identification of RNA for norovirus genogroup typing We will carry out AuMNPs separation and magnetic focusing for SERS nanoparticle detection using microchannel electrophoresis with the electroosmotic flow suppressed Working with Professor Robert Gilman of Johns Hopkins University we will carry out proof of principle work to detect genogroups I and II noroviruses in about previously collected and de identified stool samples that have been characterized by real time reverse transcription PCR qRT PCR These samples contain low medium and high concentration of virus as well as different genotypes under each group Our platform is unique as it uses multifunctional AuMNPs to provide RNA capture magnetic manipulation and SERS detection Our Phase I goal is to complete a sensitive and specific assay in min using low viral load samples Our eventual goal is to perform all the assay steps in a closed system when we integrate the detection scheme into a sample preparation cartridge that weandapos re already developing The assay when fully commercialized will be operated in automated manner PUBLIC HEALTH RELEVANCE Noroviruses are the most common cause of epidemic gastroenteritis The virus affects around million people and causes over deaths each year The viruses are transmitted by fecally contaminated food or water by person to person contact and via aerosolization of the virus and subsequent contamination of surfaces A deployable and easy to use molecular diagnostics system that provides rapid accurate and early detection of norovirus infection by public health officials private industries e g cruise ships companies and even the military will promptly alert the authorities to implement sanitizing and precaution efforts to minimize the spread of this illness and its adverse effect on the citizens customers and military readiness

Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 224.90K | Year: 2014

DESCRIPTION (provided by applicant): The aim of this application is to develop a rapid, easy-to-use, and inexpensive multi-sample diagnostic system to identify sexually transmitted infection (STI) pathogens, such as Chlamydia trachomatis (CT) and Neisseriagonorrhoeae (NG) in non-traditional healthcare settings. According to the CDC, chlamydia and gonorrhea, caused by C. trachomatis and N. gonorrhoeae, respectively, are the first and second most frequently reported STIs in the US and likely the rest of theworld. These STIs are often under-diagnosed, leading to delayed treatment, continued spread and higher public healthcare costs (~ 16 billion annually). As a result of their prevalence and long term health consequences, there is a need for rapid, sensitivemethods of detecting STIs in order for patients to get results and treatment immediately. It is important that patients receive results and initial consultation or treatment during the first patient visit, as they rarely return for a second visit. Poi

Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 209.72K | Year: 2014

DESCRIPTION (provided by applicant): This SBIR Phase I proposal aims to develop and commercialize a portable, easy-to-use system for nucleic acid preparation for effective molecular diagnostics in low-resource settings (LRS). The technology will also aid in the monitoring of treatment response for patients of global diseases such as AIDS, malaria, and tuberculosis. Because a reliable and reproducible high-quality sample preparation process for NA is critical to the success of most molecular diagnostic assays and the subsequent treatment and monitoring of recovery progress, the availability of an effective sample preparation technology is especially important if the tests are performed in non-traditional or low-resource health care settings. Most processes incurrent commercial sample preparation methods are labor intensive and require special instrumentation. Although commercially available automated systems can perform extensive sample processing, they are expensive for use in non-central laboratory set

Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 199.86K | Year: 2014

DESCRIPTION (provided by applicant): Dengue is transmitted mainly by the Aedes aegypti mosquitoes which inhabit the tropics, making Dengue endemic to these areas. It is caused by four genetically and serologically related viruses, termed DENV1, DENV2, DENV3, and DENV4. Dengue infection is a leading cause of illness and death in the tropics and subtropics, including Puerto Rico and the U.S. Virgin Islands, where thousands of U.S. citizens develop dengue fever every year. With three billion of the world's population at risk from dengue, an estimated 50-100 million cases of Dengue Fever (DF), and hundreds of thousands of cases of severe dengue (previously known as Dengue Hemorrhagic Fever or DHF) that occur every year, the demand for a rapid, sensitive, and serotype- specific dengue diagnostics test is high. Patients would be diagnosed sooner to receive treatment, and public health laboratories would have a clearer picture of the true number of dengue cases. Dengue is an acute illness where most patients ar

Discover hidden collaborations